bg
A

Avrobio (AVRO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Avrobio (AVRO)

AVROBIO, Inc. is a clinical-stage gene therapy company. The Company is focused on developing curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. Its gene therapies employ he... Read more

  • USD1.24
  • USD1.27
  • USD1.24
  • USD1.70
  • -2.30%
  • --
  • 42.12k
  • 171.93k
  • 57M
  • 0.57
  • 33.70%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.